Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
SAN DIEGO, and TORONTO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...
50% of cutaneous T-cell lymphoma patients treated with 300mg IV infusion achieved objective response ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email